BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27323402)

  • 1. Albuminuria enhances NHE3 and NCC via stimulation of mitochondrial oxidative stress/angiotensin II axis.
    Jia Z; Zhuang Y; Hu C; Zhang X; Ding G; Zhang Y; Rohatgi R; Hua H; Huang S; He JC; Zhang A
    Oncotarget; 2016 Jul; 7(30):47134-47144. PubMed ID: 27323402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-mediated biphasic regulation of proximal tubular Na+/H+ exchanger 3 is impaired during oxidative stress.
    Banday AA; Lokhandwala MF
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F364-70. PubMed ID: 21593187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease.
    Zhang Y; Sun Y; Ding G; Huang S; Zhang A; Jia Z
    Sci Rep; 2015 Jul; 5():12480. PubMed ID: 26207612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity.
    Giani JF; Eriguchi M; Bernstein EA; Katsumata M; Shen XZ; Li L; McDonough AA; Fuchs S; Bernstein KE; Gonzalez-Villalobos RA
    Kidney Int; 2017 Apr; 91(4):856-867. PubMed ID: 27988209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal upregulation of NCC counteracts empagliflozin-mediated NHE3 inhibition in normotensive but not in hypertensive male rat.
    Castro PC; Santos-Rios TM; Martins FL; Crajoinas RO; Caetano MV; Lessa LMA; Luchi WM; McCormick JA; Girardi ACC
    Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1573-C1589. PubMed ID: 38557357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction confers albumin-induced NLRP3 inflammasome activation and renal tubular injury.
    Zhuang Y; Yasinta M; Hu C; Zhao M; Ding G; Bai M; Yang L; Ni J; Wang R; Jia Z; Huang S; Zhang A
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F857-66. PubMed ID: 25694478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal nerve stimulation leads to the activation of the Na+/H+ exchanger isoform 3 via angiotensin II type I receptor.
    Pontes RB; Crajoinas RO; Nishi EE; Oliveira-Sales EB; Girardi AC; Campos RR; Bergamaschi CT
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F848-56. PubMed ID: 25656367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II-Induced Hypertension.
    Shao S; Li XD; Lu YY; Li SJ; Chen XH; Zhou HD; He S; Guo YT; Lu X; Gao PJ; Wang JG
    Hypertension; 2021 Mar; 77(3):868-881. PubMed ID: 33486984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress causes renal angiotensin II type 1 receptor upregulation, Na+/H+ exchanger 3 overstimulation, and hypertension.
    Banday AA; Lokhandwala MF
    Hypertension; 2011 Mar; 57(3):452-9. PubMed ID: 21282559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megalin is involved in angiotensinogen-induced, angiotensin II-mediated ERK1/2 signaling to activate Na + -H + exchanger 3 in proximal tubules.
    Goto S; Yoshida Y; Hosojima M; Kuwahara S; Kabasawa H; Aoki H; Iida T; Sawada R; Ugamura D; Yoshizawa Y; Takemoto K; Komochi K; Kobayashi R; Kaseda R; Yaoita E; Nagatoishi S; Narita I; Tsumoto K; Saito A
    J Hypertens; 2023 Nov; 41(11):1831-1843. PubMed ID: 37682076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of stimulated intrarenal angiotensinogen in hypertension.
    Satou R; Shao W; Navar LG
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):181-90. PubMed ID: 25987608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Na+/H+ exchanger 3 in angiotensin II-induced hypertension.
    Li XC; Shull GE; Miguel-Qin E; Zhuo JL
    Physiol Genomics; 2015 Oct; 47(10):479-87. PubMed ID: 26242933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
    Yang XH; Wang YH; Wang JJ; Liu YC; Deng W; Qin C; Gao JL; Zhang LY
    Peptides; 2012 Jul; 36(1):60-70. PubMed ID: 22580272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked.
    Sartori-Valinotti JC; Iliescu R; Yanes LL; Dorsett-Martin W; Reckelhoff JF
    Hypertension; 2008 Apr; 51(4):1170-6. PubMed ID: 18259017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology.
    Xie P; Joladarashi D; Dudeja P; Sun L; Kanwar YS
    Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1260-74. PubMed ID: 24553435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells.
    Liu BC; Gao J; Li Q; Xu LM
    Clin Chim Acta; 2009 May; 403(1-2):23-30. PubMed ID: 19141296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of intrarenal ACE protects against hypertension.
    Gonzalez-Villalobos RA; Janjoulia T; Fletcher NK; Giani JF; Nguyen MT; Riquier-Brison AD; Seth DM; Fuchs S; Eladari D; Picard N; Bachmann S; Delpire E; Peti-Peterdi J; Navar LG; Bernstein KE; McDonough AA
    J Clin Invest; 2013 May; 123(5):2011-23. PubMed ID: 23619363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MnTBAP therapy attenuates the downregulation of sodium transporters in obstructive kidney disease.
    Liu M; Zhu Y; Sun Y; Wen Z; Huang S; Ding G; Zhang A; Jia Z; Zhang Y
    Oncotarget; 2018 Jan; 9(1):394-403. PubMed ID: 29416622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.